US OptionsDetailed Quotes
AMRX250117C10000
- 0.05
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume3.88K Open Interest10.00Strike Price0.00Turnover0.00%IV15.78%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-7DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma173.60Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Amneal Pharmaceuticals Stock Discussion
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards to ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards to ...
47
15
6
$Amneal Pharmaceuticals (AMRX.US)$
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Amneal Pharmaceuticals (AMRX) has received FDA approval for two products and one tentative approval: memantine/donepezil extended-release capsules for Alzheimer's dementia treatment (with 180-day exclusivity), everolimus tablets for treating Tuberous Sclerosis Complex, and tentative ap...
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Amneal Pharmaceuticals (AMRX) has received FDA approval for two products and one tentative approval: memantine/donepezil extended-release capsules for Alzheimer's dementia treatment (with 180-day exclusivity), everolimus tablets for treating Tuberous Sclerosis Complex, and tentative ap...
$Amneal Pharmaceuticals (AMRX.US)$ Reuters· 3 mins ago
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
NOTE:
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
4. If you are expecting all stocks to be a runner,then you are set for failure, losses, and bagholding. Not all good news run and not all bad news crash the pri...
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
4. If you are expecting all stocks to be a runner,then you are set for failure, losses, and bagholding. Not all good news run and not all bad news crash the pri...
67
19
12
$Amneal Pharmaceuticals (AMRX.US)$ Reuters· 2 mins ago
Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
$Amneal Pharmaceuticals (AMRX.US)$ Reuters· just
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets
$Amneal Pharmaceuticals (AMRX.US)$ Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
5 MINUTES AGO, 6:00 AM EDT
VIA BUSINESSWIRE
Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera's portfolio of novel injectable and oral development programs, including GLP-1 and amylin receptor agonists
Agreement provides Amneal w...
5 MINUTES AGO, 6:00 AM EDT
VIA BUSINESSWIRE
Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera's portfolio of novel injectable and oral development programs, including GLP-1 and amylin receptor agonists
Agreement provides Amneal w...
$Amneal Pharmaceuticals (AMRX.US)$ Reuters
Amneal and Shilpa Announce U.S. FDA Approval of Boruzu™, the First Ready-to-Use Version of Bortezomib for Subcutaneous Administration
Amneal and Shilpa Announce U.S. FDA Approval of Boruzu™, the First Ready-to-Use Version of Bortezomib for Subcutaneous Administration
2
45
No comment yet
74537207 : thank you
, your list helps a lot to narrow things down and do my own research, you are doing great work day after day!
nowuuuh : check out $8x8 (EGHT.US)$ too. earnings on the 4th
Jaguar8 OP nowuuuh : likely for Feb 4 ER
103851773 : Thanks Jag bro![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
HailTheApocalypse : thank you Mr. Jaguar
View more comments...